CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-05 | Morgan Amanda Michelle Chief Commercial Officer | Grant or award | +26,208 | 64,748 | ||
| 2026-03-05 | Morgan Amanda Michelle Chief Commercial Officer | Shares withheld for taxes | −595 | $76.31 | $45K | 64,153 |
| 2026-03-02 | Morgan Amanda Michelle Chief Commercial Officer | Grant or award | +2,782 | 41,876 | ||
| 2026-03-02 | Morgan Amanda Michelle Chief Commercial Officer | Shares withheld for taxes | −3,336 | $76.30 | $255K | 38,540 |
| 2025-12-15 | Morgan Amanda Michelle Chief Commercial Officer | Shares withheld for taxes | −368 | $66.57 | $24K | 39,094 |
| 2025-03-05 | Morgan Amanda Michelle Chief Commercial Officer | Grant or award | +14,928 | 39,580 | ||
| 2025-03-05 | Morgan Amanda Michelle Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +8,704 | 8,704 | ||
| 2025-03-03 | Morgan Amanda Michelle Chief Commercial Officer | Shares withheld for taxes | −759 | $94.86 | $72K | 24,652 |
| 2024-12-15 | Morgan Amanda Michelle Chief Commercial Officer | Shares withheld for taxes | −356 | $93.48 | $33K | 25,055 |
Page 1 of 1 · 9 trades